Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis
Abstract Background Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We performed a systematic review and meta-analysis of randomized clinical trials...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-06-01
|
| Series: | Clinical Hypertension |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40885-019-0116-x |